Meditect operates in the pharmaceutical industry, focusing on ensuring the authenticity and safety of medications in Sub-Saharan Africa. The company leverages blockchain technology to create a secure and transparent system for tracking pharmaceuticals from manufacturers to pharmacies. Meditect primarily serves pharmacies and healthcare providers, offering them a digital platform to verify the legitimacy of medications, thereby combating the prevalent issue of counterfeit drugs in the region. The business model revolves around a subscription-based service where clients pay for access to the platform and its features. Revenue is generated through these subscriptions as well as potential partnerships with pharmaceutical companies and healthcare organizations. Meditect's market is primarily in Sub-Saharan Africa, where the need for secure pharmaceutical supply chains is critical. The company has gained recognition for its innovative approach, winning awards such as the 'Blockchain Innovation Challenge' at Columbia University.

Keywords: blockchain, pharmaceutical, authenticity, safety, Sub-Saharan Africa, digital platform, counterfeit drugs, healthcare, subscription-based, supply chain.